Prevention of stent thrombosis: challenges and solutions
- PMID: 25657588
- PMCID: PMC4315466
- DOI: 10.2147/VHRM.S43357
Prevention of stent thrombosis: challenges and solutions
Abstract
Stent thrombosis is an uncommon but serious complication which carries with it significant mortality and morbidity. This review analyzes the entity of stent thrombosis from a historical and clinical perspective, and chronicles the evolution of this condition through the various generations of stent development, from bare metal to first-generation, second-generation, and third-generation drug-eluting stents. It also delineates the specific risk factors associated with stent thrombosis and comprehensively examines the literature related to each of these risks. Finally, it highlights the preventative strategies that can be garnered from the existing data, and concludes that a multifactorial approach is necessary to combat the occurrence of stent thrombosis, with higher risk groups, such as patients with ST segment elevation myocardial infarction, meriting further research.
Keywords: post-procedural myocardial infarction; preventative strategies; stent thrombosis.
Figures


Similar articles
-
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011. JACC Cardiovasc Interv. 2013. PMID: 23968698 Clinical Trial.
-
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017. Epub 2014 Sep 17. JACC Cardiovasc Interv. 2014. PMID: 25240540
-
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15. JACC Cardiovasc Interv. 2013. PMID: 23683734 Clinical Trial.
-
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.Cardiovasc Ther. 2015 Dec;33(6):360-6. doi: 10.1111/1755-5922.12160. Cardiovasc Ther. 2015. PMID: 26363283 Review.
-
Stent thrombosis: a clinical perspective.JACC Cardiovasc Interv. 2014 Oct;7(10):1081-92. doi: 10.1016/j.jcin.2014.05.016. JACC Cardiovasc Interv. 2014. PMID: 25341705 Review.
Cited by
-
An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary Intervention.J Manag Care Spec Pharm. 2018 Feb;24(2):142-152. doi: 10.18553/jmcp.2018.24.2.142. J Manag Care Spec Pharm. 2018. PMID: 29384027 Free PMC article.
-
219Three-dimensional printing as a cutting-edge, versatile and personalizable vascular stent manufacturing procedure: Toward tailor-made medical devices.Int J Bioprint. 2023 Jan 9;9(2):664. doi: 10.18063/ijb.v9i2.664. eCollection 2023. Int J Bioprint. 2023. PMID: 37065659 Free PMC article.
-
A case of "very" very late stent thrombosis: More than 12 years after DES.J Family Med Prim Care. 2022 Apr;11(4):1545-1548. doi: 10.4103/jfmpc.jfmpc_1533_21. Epub 2022 Mar 18. J Family Med Prim Care. 2022. PMID: 35516662 Free PMC article.
-
Shear-Mediated Platelet Activation is Accompanied by Unique Alterations in Platelet Release of Lipids.Cell Mol Bioeng. 2021 Aug 25;14(6):597-612. doi: 10.1007/s12195-021-00692-x. eCollection 2021 Dec. Cell Mol Bioeng. 2021. PMID: 34900013 Free PMC article.
-
One-Month Outcomes of Cases Receiving Ticagrelor after Percutaneous Coronary Intervention; a Case Series.Arch Acad Emerg Med. 2020 Mar 30;8(1):e42. eCollection 2020. Arch Acad Emerg Med. 2020. PMID: 32259131 Free PMC article.
References
-
- Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701–706. - PubMed
-
- Cutlip DE, Windecker S, Mehran R, et al. Academic Research Consortium. Academic Research Consortium clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351. - PubMed
-
- Cutlip DE, Nakazawa G, Krucoff MW, et al. Autopsy validation study of the Academic Research Consortium stent thrombosis definition. JACC Cardiovasc Interv. 2011;4:554–559. - PubMed
-
- Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44–e122. - PubMed
-
- Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134–1140. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources